Wide-reaching report finds strong support for nurse and pharmacist prescribing

Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report

 

Southampton (May 10, 2011) – Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report.

 

Health service researchers from the universities of Southampton and Keele found widespread acceptance of the new powers among patients and that prescribing practices were safe and appropriate for the type of medical conditions being treated.

 

The Department of Health-funded report, published today (Tuesday, 10 May 2011), gives a national ’snapshot‘ of how successfully nurse and pharmacist prescribing is being used in primary care trusts, GP surgeries and hospitals.

 

"This study is the first national evaluation of independent prescribing by nurses and pharmacists since legislation in 2006 enabled nurses and pharmacists to independently prescribe across an extensive range of medicines. Our research shows that the practice is becoming a well–integrated and established means of managing a patient’s condition," comments Sue Latter, professor of nursing at the University of Southampton, who led the study.

 

"We were also able to highlight areas to the government where expansion of non-medical prescribing could strengthen NHS services in order to meet health care needs of the future."

 

The legislation, which gave experienced nurses and pharmacists powers to prescribe medication to patients, was viewed by some as controversial when it was introduced in 2006. Specially trained nurses and pharmacists in England are now able to manage all aspects of a patient’s treatment including diagnosis, prescription and monitoring, without supervision by a doctor.

 

"Our research shows that nurse and pharmacist independent prescribers are now making a substantial contribution to patient care which is safe and of good quality," says Alison Blenkinsopp, professor of the practice of pharmacy at Keele University.

 

"Commissioners of healthcare can use our findings to make the most effective use of nurse and pharmacist prescribing when they are commissioning services."

 

The report also found that:

 

  • 86 per cent of nurses and 71 per cent of pharmacists are using their new powers after training as a prescriber.
  • Most nurses and pharmacists are prescribing in a primary care setting, with substantial numbers also in secondary care settings, such as hospitals.
  • Most patients did not mind whether they received care from a nurse, pharmacist or a doctor.
  • Enabling non-medical prescribing to develop further, by additional training of nurses and pharmacists to treat patients with more than one medical condition, could improve patient care and efficiency in the health service.

 


 

University of Southampton, Sophie Docker; Nursing News 10.05.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…